跳至主要内容
临床试验/CTRI/2012/04/002551
CTRI/2012/04/002551已完成4 期

To assess the efficacy, quality of life and safety of IDCTM (Integral Dermo Correction) products in patients with wrinkles on the face

Glenmark Pharmaceuticals Limited0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • Subjects with wrinkles (Class 1 to 3)
  • Age group (AWF â?? Women: 35 to 50 yrs; AWF â?? Men: 35 years and above; Deep wrinkles : 35 yrs and above)
  • Willing to restrain from prolonged exposure to the sun for the length of the study
  • Available for the entire duration of the study

排除标准

  • Hypersensitivity to any ingredients
  • Pregnant and lactating women.
  • Subjects who are applying anti-aging anti-wrinkle or AHA (Alpha hydroxy acids) based or retinol based cosmetics or have applied any of these in the last 3 months.
  • Subjects with dermatological disorder of face that may interfere with study evaluation.
  • Subjects who have undergone any surgical treatment of the face

研究者

相似试验